Geojit BNP Paribas
The formulation business has registered a de-growth of 16% owing to the general slowness in the segment. With a strong order book and customer base in the CDMO segment , the company is poised to sustain its growth momentum in the long term....
Cohance Lifesciences Ltd. is trading below its 100 day SMA of 418.8
More from Cohance Lifesciences Ltd.
Recommended